We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Most cancer tissues showed weak to moderate cytoplasmic immunoreactivity. Most cases of gliomas, renal and skin cancers were negative.
GENE INFORMATION
Gene name
LMO2 (HGNC Symbol)
Synonyms
RBTN2, RBTNL1, RHOM2, TTG2
Description
LIM domain only 2 (rhombotin-like 1) (HGNC Symbol)
Entrez gene summary
LMO2 encodes a cysteine-rich, two LIM-domain protein that is required for yolk sac erythropoiesis. The LMO2 protein has a central and crucial role in hematopoietic development and is highly conserved. The LMO2 transcription start site is located approximately 25 kb downstream from the 11p13 T-cell translocation cluster (11p13 ttc), where a number T-cell acute lymphoblastic leukemia-specific translocations occur. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Nov 2008]
Predicted intracellular proteins Cancer-related genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Disease related genes Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000977 [RNA polymerase II regulatory region sequence-specific DNA binding] GO:0000981 [RNA polymerase II transcription factor activity, sequence-specific DNA binding] GO:0001102 [RNA polymerase II activating transcription factor binding] GO:0001190 [transcriptional activator activity, RNA polymerase II transcription factor binding] GO:0001228 [transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding] GO:0003682 [chromatin binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005667 [transcription factor complex] GO:0007275 [multicellular organismal development] GO:0008270 [zinc ion binding] GO:0035162 [embryonic hemopoiesis] GO:0042789 [mRNA transcription from RNA polymerase II promoter] GO:0043425 [bHLH transcription factor binding] GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] GO:0048037 [cofactor binding] GO:0070888 [E-box binding] GO:0097067 [cellular response to thyroid hormone stimulus]
Predicted intracellular proteins Cancer-related genes COSMIC somatic mutations in cancer genes COSMIC Somatic Mutations COSMIC Translocations Disease related genes Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000977 [RNA polymerase II regulatory region sequence-specific DNA binding] GO:0000981 [RNA polymerase II transcription factor activity, sequence-specific DNA binding] GO:0001102 [RNA polymerase II activating transcription factor binding] GO:0001190 [transcriptional activator activity, RNA polymerase II transcription factor binding] GO:0001228 [transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005667 [transcription factor complex] GO:0007275 [multicellular organismal development] GO:0008270 [zinc ion binding] GO:0042789 [mRNA transcription from RNA polymerase II promoter] GO:0043425 [bHLH transcription factor binding] GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] GO:0048037 [cofactor binding] GO:0070888 [E-box binding] GO:0097067 [cellular response to thyroid hormone stimulus]